Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Camptothecin also abrogated the TNF-induced NF-κB Activation
AG14361 (30 mg/kg) synergizes lestaurtinib activity on inhibiting breast cancer tumors in allografts
Formula: C19H23ClFN3O4
InChi: InChI=1S/C20H25N5O3/c26-17(10-25-6-5-14-3-1-2-4-15(14)9-25)8-21-20(27)18-7-19(23-13-22-18)24-16-11-28-12-16/h1-4
Formula: C15H15NO
NS-304 Size:Solid 2 mg Camptothecin also abrogated the TNF-inducedSelexipag, also known as ACT 293987 and NS 304, is a a first in class orally available selective non prostanoid IP receptor agonist, which is currently in development by Actelion as a treatment of pulmonary arterial hypertension. Selexipag and its active metabolite, ACT 333679, are agonists at the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation. Product information CAS Number: 475086 01 2 Molecular Weight: 496. 62